Breast Carcinoma Clinical Trials in Boston, Massachusetts

5 studies are recruiting for breast carcinoma in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Supporting Health Including Endocrine Treatment for Long Duration

   This research is being done to pilot an intervention which aims to test a new web- and mobile application ("app")-based supportive care tool (SHIELD portal) and to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease long-term endocrine treatment.

   Stage

   Not phased

   Ages

   18 to 49

   Site

   Dana-Farber Cancer Institute, Boston, Massachusetts

   Run by

   Dana-Farber Cancer Institute

   See if you can join NCT07482384 on ClinicalTrials.gov

2. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

   This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works …

   Stage

   Phase 2

   Ages

   18 to 55

   Site

   Dana-Farber Cancer Institute, Boston, Massachusetts

   Locations

   11 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT06184750 on ClinicalTrials.gov

3. Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

   This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with hypertension receiving bevacizumab for breast cancer. Studying samples of germline DNA in the laboratory from patients with hypertension receiving beva…

   Stage

   Not phased

   Ages

   Any age

   Site

   Eastern Cooperative Oncology Group, Boston, Massachusetts

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT02610413 on ClinicalTrials.gov

4. Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

   This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with congestive heart failure receiving therapy for breast cancer. Studying samples of germline DNA in the laboratory from patients with congestive heart fa…

   Stage

   Not phased

   Ages

   Any age

   Site

   Eastern Cooperative Oncology Group, Boston, Massachusetts

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT02610426 on ClinicalTrials.gov

5. Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

   This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with peripheral neuropathy receiving chemotherapy for breast cancer. Studying samples of germline DNA in the laboratory from patients with peripheral neurop…

   Stage

   Not phased

   Ages

   Any age

   Site

   Eastern Cooperative Oncology Group, Boston, Massachusetts

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT02610439 on ClinicalTrials.gov